Uridin-hand-foot-ointment and uridin-mucous membrane paste;Uridin-hand-fuss-salbe und uridin-haftpaste: Antidota nach akzidenteller hautkontamination mit fluorouracil - Ein fallbericht

Krankenhauspharmazie

Volumn 21, Issue 12, 2000, Pages 625-628

  Barth, J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Antidote; Extemporaneous formulation; Fluorouracil; Skin contamination; Uridin hand foot ointment; Uridin mucous membrane paste

Indexed keywords

ANTIDOTE; FLUOROURACIL; URIDINE DERIVATIVE;

ARTICLE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG FORMULATION; HUMAN; OINTMENT; SKIN IRRITATION;

EID: 0033668743     PISSN: 01737597     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Antimetabolites
2. Fluorouracil and palmarplantar erythrodysesthesia
3. Assessment of growth-limiting events by 5-fluorouracil in mouse cells and in human cells
4. Fluorouracil-associated dermatitis of the hands and feet
5. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine
6. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil
7. Uridine rescue from the lethal toxicity of 5-fluorouracil in mice
8. A prospective randomized comparison of continuous infusion fluorouracil with a convcntional bolus schedule in metastatic colorectal carcinoma: A mid-atlantic oncology program study
9. High-dose 5-fluorouracil with delayed uridine 'rescue' in mice
10. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse Tlymphoma (S-49) cells
11. In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil
12. Fluouracil: Biochemistry and pharmacology
13. Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin
14. Fluorouracil in colorectal cancer - A tale of two drugs: Implications for biochemical modulation
15. Comparative studies of fluorinated pyrimidines with various cell lines
16. Combination clinical trials with thymidine and fluorouracil: A phase I and clinical pharmacologic evaluation